• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟雾病患者血清基质金属蛋白酶-9表达增加。

Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.

作者信息

Fujimura Miki, Watanabe Mika, Narisawa Ayumi, Shimizu Hiroaki, Tominaga Teiji

机构信息

Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.

出版信息

Surg Neurol. 2009 Nov;72(5):476-80; discussion 480. doi: 10.1016/j.surneu.2008.10.009. Epub 2009 Jan 14.

DOI:10.1016/j.surneu.2008.10.009
PMID:19147196
Abstract

BACKGROUND

Moyamoya disease is a chronic occlusive cerebrovascular disease with unknown etiology characterized by an abnormal vascular network at the base of the brain, which can manifest both as ischemic stroke and as cerebral hemorrhage. It was also reported that the patients with moyamoya disease are more vulnerable to cerebral hyperperfusion such as postoperative hemorrhagic complication after extracranial-intracranial bypass surgery despite its low flow revascularization. However, the underlying mechanisms of its pathologic angiogenesis and the occurrence of hemorrhage are undetermined. Excessive degradation of the vascular matrix by MMPs, proteolytic enzymes that degrade all the components of extracellular matrix, can lead to instability of the vascular structure and can thereby cause bleeding. The MMPs also play an important role in tissue remodeling including angiogenesis in both physiologic and pathologic condition.

METHODS

We examined the serum levels of MMP-2 and MMP-9 in 16 cases with definitive moyamoya disease by enzyme-linked immunosorbent assay and compared them with those from healthy controls.

RESULTS

The serum MMP-9 level was significantly higher in moyamoya disease (40.18 ng/mL) than in healthy controls (13.75 ng/mL, P = .0372). There was no difference in serum MMP-2 level between moyamoya disease (646.65 ng/mL) and healthy control (677.60 ng/mL). Immunohistochemistry on the surgical specimens showed significant increase in MMP-9 expression within the arachnoid membrane of moyamoya disease.

CONCLUSION

The increased expression of MMP-9 may contribute to pathologic angiogenesis and/or to the instability of the vascular structure and could thereby cause hemorrhage in moyamoya disease.

摘要

背景

烟雾病是一种病因不明的慢性闭塞性脑血管疾病,其特征是脑底部出现异常血管网,可表现为缺血性卒中或脑出血。也有报道称,烟雾病患者更容易发生脑过度灌注,如颅外-颅内旁路手术后的术后出血并发症,尽管其血运重建流量较低。然而,其病理性血管生成和出血发生的潜在机制尚不清楚。基质金属蛋白酶(MMPs)是一种能降解细胞外基质所有成分的蛋白水解酶,其对血管基质的过度降解可导致血管结构不稳定,进而引起出血。MMPs在包括生理和病理状态下的血管生成在内的组织重塑中也发挥着重要作用。

方法

我们通过酶联免疫吸附测定法检测了16例确诊烟雾病患者的血清MMP-2和MMP-9水平,并与健康对照者的水平进行比较。

结果

烟雾病患者的血清MMP-9水平(40.18 ng/mL)显著高于健康对照者(13.75 ng/mL,P = 0.0372)。烟雾病患者(646.65 ng/mL)与健康对照者(677.60 ng/mL)的血清MMP-2水平无差异。手术标本的免疫组织化学显示,烟雾病蛛网膜内MMP-9表达显著增加。

结论

MMP-9表达增加可能导致烟雾病的病理性血管生成和/或血管结构不稳定,从而引起出血。

相似文献

1
Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.烟雾病患者血清基质金属蛋白酶-9表达增加。
Surg Neurol. 2009 Nov;72(5):476-80; discussion 480. doi: 10.1016/j.surneu.2008.10.009. Epub 2009 Jan 14.
2
Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2.脑海绵状血管畸形中基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMP)的表达:MMP - 2、- 9和TIMP - 2的免疫组织化学分析
Acta Neurochir (Wien). 2007 Feb;149(2):179-83; discussion 183. doi: 10.1007/s00701-006-0929-8. Epub 2006 Oct 18.
3
Peripheral thermal injury causes blood-brain barrier dysfunction and matrix metalloproteinase (MMP) expression in rat.外周热损伤会导致大鼠血脑屏障功能障碍和基质金属蛋白酶(MMP)表达。
Brain Res. 2007 Jan 19;1129(1):26-33. doi: 10.1016/j.brainres.2006.10.061. Epub 2006 Dec 6.
4
Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease.评估 Eales 病患者玻璃体液和血清中明胶酶和肿瘤坏死因子-α水平:炎症介导的血管生成在 Eales 病发病机制中的作用。
Retina. 2011 Jul-Aug;31(7):1412-20. doi: 10.1097/IAE.0b013e318203c199.
5
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.肥厚型心肌病中的基质金属蛋白酶与组织重塑
Am Heart J. 2008 Jul;156(1):85-91. doi: 10.1016/j.ahj.2008.01.035.
6
[Study on expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in brain tissue adjacent to hemorrhage after brain hemorrhage in human].
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Jun;19(6):336-9.
7
Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.营养不良性mdx小鼠大脑中基质金属蛋白酶-2和基质金属蛋白酶-9表达增加。
Neuroscience. 2006 Jul 7;140(3):835-48. doi: 10.1016/j.neuroscience.2006.02.077. Epub 2006 May 2.
8
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.血清中基质金属蛋白酶-9和基质金属蛋白酶-1水平升高与转移性黑色素瘤患者的快速进展相关。
Clin Cancer Res. 2005 Jul 15;11(14):5158-66. doi: 10.1158/1078-0432.CCR-04-2478.
9
Significant elevation of plasma matrix metalloproteinase-9 level and its ratio to matrix metalloproteinase-2 in patients with pelvic inflammatory disease.盆腔炎患者血浆基质金属蛋白酶-9水平及其与基质金属蛋白酶-2的比值显著升高。
Fertil Steril. 2009 Nov;92(5):1679-84. doi: 10.1016/j.fertnstert.2008.08.113. Epub 2008 Oct 19.
10
Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.烟雾病患者颞浅动脉-大脑中动脉吻合术后迟发性脑出血:可能与脑血流过度灌注及血管通透性增加有关。
Surg Neurol. 2009 Feb;71(2):223-7; discussion 227. doi: 10.1016/j.surneu.2007.07.077. Epub 2008 Mar 4.

引用本文的文献

1
Association between intracranial vascular vulnerability and indirect revascularization development in moyamoya disease.烟雾病中颅内血管脆弱性与间接血运重建发展之间的关联
Neurosurg Rev. 2025 Apr 25;48(1):387. doi: 10.1007/s10143-025-03544-8.
2
Decreased Lactococcus lactis and Propionic Acid in Feces of Patients with Moyamoya Disease: Possible Implications of Immune Dysregulation.烟雾病患者粪便中乳酸乳球菌和丙酸减少:免疫失调的可能影响
Cerebrovasc Dis. 2025 Mar 26:1-9. doi: 10.1159/000545478.
3
Medical Management of Adult Moyamoya Disease: A Review and Relevant Cases With Ischemic Events.
成人烟雾病的医学管理:综述及缺血性事件相关病例
J Stroke. 2025 Jan;27(1):1-18. doi: 10.5853/jos.2024.04273. Epub 2025 Jan 31.
4
Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions.烟雾病的进展:发病机制、诊断及治疗干预
MedComm (2020). 2025 Jan 14;6(2):e70054. doi: 10.1002/mco2.70054. eCollection 2025 Feb.
5
Genome-Wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease.全基因组DNA甲基化分析揭示烟雾病中甲基化变异性较低
Transl Stroke Res. 2024 Oct 2. doi: 10.1007/s12975-024-01299-w.
6
Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells.敲低烟雾病易感基因 RNF213 可上调骨髓间充质干细胞中碱性成纤维细胞生长因子和基质金属蛋白酶-9 的表达。
Neurosurg Rev. 2024 May 30;47(1):246. doi: 10.1007/s10143-024-02448-3.
7
Molecular Biomarkers Affecting Moyamoya Disease.影响烟雾病的分子生物标志物。
Adv Tech Stand Neurosurg. 2024;49:1-18. doi: 10.1007/978-3-031-42398-7_1.
8
Identification of diagnostic markers for moyamoya disease by combining bulk RNA-sequencing analysis and machine learning.结合批量RNA测序分析和机器学习鉴定烟雾病的诊断标志物
Sci Rep. 2024 Mar 11;14(1):5931. doi: 10.1038/s41598-024-56367-w.
9
Angiogenic and inflammatory responses in human induced microglia-like (iMG) cells from patients with Moyamoya disease.人类烟雾病诱导小胶质细胞(iMG)中血管生成和炎症反应。
Sci Rep. 2023 Sep 8;13(1):14842. doi: 10.1038/s41598-023-41456-z.
10
The Pathophysiology of Collateral Circulation in Acute Ischemic Stroke.急性缺血性卒中侧支循环的病理生理学
Diagnostics (Basel). 2023 Jul 20;13(14):2425. doi: 10.3390/diagnostics13142425.